Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$83.3K Buy
+230
New +$78.7K 0.01% 75
2023
Q4
Sell
-2,900
Closed -$779K 20
2023
Q3
$779K Buy
+2,900
New +$724K 0.47% 27
2023
Q1
Sell
-2,900
Closed -$762K 27
2022
Q4
$762K Sell
2,900
-2,000
-41% -$536K 0.38% 97
2022
Q3
$1.1M Sell
4,900
-100
-2% -$24.2K 0.81% 32
2022
Q2
$1.22M Buy
+5,000
New +$1.23M 0.81% 29
2021
Q2
Sell
-3,700
Closed -$921K 22
2021
Q1
$921K Buy
+3,700
New +$883K 0.08% 111
2020
Q4
Sell
-4,000
Closed -$1.02M 27
2020
Q3
$1.02M Buy
+4,000
New +$991K 0.31% 24

Other funds holding AMGN

Toews Corporation's AMGN Position: Q2 2026 in Review

Toews Corporation opened a new position in Amgen (AMGN) in Q2 2026: 230 shares worth $83.3K. The stake represents 0.01% of the portfolio and ranks #75 among its holdings. This is a return to the name: Toews Corporation previously reported a position in AMGN as recently as Q3 2023.

Toews Corporation first reported a position in AMGN in Q3 2020 and has held it in 7 quarters since. The position peaked at $1.22M in Q2 2022. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Toews Corporation held 230 shares of Amgen worth $83.3K as of Q2 2026.
  • Amgen was a new Toews Corporation position in Q2 2026.
  • Amgen made up 0.01% of Toews Corporation's portfolio in Q2 2026, its #75 holding.
  • Toews Corporation first reported a position in Amgen in Q3 2020 and has held it in 7 quarters since.
  • Toews Corporation's Amgen position peaked at $1.22M in Q2 2022.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Toews Corporation's 13F filing for Q2 2026, filed 10 Aug 2026.